SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-17-003277
Filing Date
2017-12-11
Accepted
2017-12-11 16:29:53
Documents
60
Period of Report
2017-10-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q peregrine_10q-103117.htm 10-Q 355422
2 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER peregrine_ex3101.htm EX-31.1 8281
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER peregrine_ex3102.htm EX-31.2 7931
4 CERTIFICATION peregrine_ex3200.htm EX-32 5887
  Complete submission text file 0001683168-17-003277.txt   2667798

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE pphm-20171031.xml EX-101.INS 519694
6 XBRL SCHEMA FILE pphm-20171031.xsd EX-101.SCH 27976
7 XBRL CALCULATION FILE pphm-20171031_cal.xml EX-101.CAL 50994
8 XBRL DEFINITION FILE pphm-20171031_def.xml EX-101.DEF 98615
9 XBRL LABEL FILE pphm-20171031_lab.xml EX-101.LAB 203755
10 XBRL PRESENTATION FILE pphm-20171031_pre.xml EX-101.PRE 186438
Mailing Address 14282 FRANKLIN AVE TUSTIN CA 92780
Business Address 14282 FRANKLIN AVE TUSTIN CA 92780 7145086000
PEREGRINE PHARMACEUTICALS INC (Filer) CIK: 0000704562 (see all company filings)

IRS No.: 953698422 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 10-Q | Act: 34 | File No.: 001-32839 | Film No.: 171249770
SIC: 2834 Pharmaceutical Preparations